Role of nitric oxide in growth of solid tumours: A balancing act

Essays in Biochemistry

Volumn 32, Issue , 1997, Pages 61-72

  Chinje, Edwin C ^a   Stratford, Ian J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; LYMPHOKINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ANOXIA; CELL DIVISION; DRUG EFFECT; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW;

ANIMALS; ANOXIA; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; ESTROGENS; HUMANS; LYMPHOKINES; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031306928     PISSN: 00711365     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064
2. Knowles, R.G. & Moncada, S. (1994) Nitric oxide synthase in mammals. J. Biochem. J. 298, 249-258
3. Bredt, D.S., Hwang, P.M., Glatt, C.E., Lowenstein, C., Reed, R.R. & Snyder, S.H. (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature (London) 351, 714-718
4. Moncada, S. & Higgs, A. (1993) The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 202-212
5. Stalmer, J.S., Singel, D.J. & Loscalzo, J. (1992) Biochemistry of nitric oxide and its redox-activated forms. Science 258, 1898-1902
6. Stuehr, D.J. & Nathan, C.F. (1989) Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumour target cells. J. Exp. Med. 169, 1543-1555
7. Pipili-Synetos, E., Sakkoula, E., & Maragoudakis, M.E. (1993) Nitric oxide is involved in the regulation of angiogenesis. Br. J. Pharmacol. 108, 855-857
8. G-nitro-L-arginine and L-arginine on experimental pulmonary metastasis in mice. Cancer Lett. 87, 115-120
9. Pipili-Synetos, E., Papageorgiou, A., Sakkoula, E., et al. (1995) Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br. J. Pharmacol. 116, 1829-1834
10. Folkman, J. & Shing, Y. (1992) Angiogenesis: A minireview. J. Biol. Chem. 267, 10931-10934
11. Dong, Z., Staroselselsky, A.M., Qi, X., Xie, K. & Fidler, I.J. (1994) Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1 735 murine melanoma cells. Cancer Res. 54, 789-793
12. Xie, K.P., Dong, Z.Y. & Fidler, I.J. (1996) Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukocyte Biol. 59, 797-803
13. Jenkins, D.C., Charles, I.G., Thomsen, L.L., et al. (1995) Roles of nitric oxide in tumour growth. Proc. Natl. Acad. Sci. U.S.A. 92, 4392-4396
14. Xie, K., Huang, S., Dong, Z., et al. (1995) Transfection with inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181, 1333-1343
15. Machiarini, P., Fontanini, G., Hardin, M.J., Squartini, F. & Angeletti, C.A. (1992) Relation of neovascularization to metastasis of non-small-cell lung-cancer. Lancet 340, 145-146
16. Andrade, S.P., Hart, I.R. & Piper, P.J. (1992) Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br. J. Pharmacol. 107, 1092-1097
17. Buttery, L.D.K., Springall, D.R., Andrade, S.P., et al. (1993) Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice. J. Pathol. 171, 311-319
18. Maeda, H., Noguchi, Y., Sato, K. & Akaike, T. (1994) Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn. J. Cancer Res. 85, 331-334
19. Doi, K., Akaike, T., Horie, H., et al. (1996) Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 77 (suppl), 1598-1604
20. G-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice. Cell. Immunol. 169, 125-132
21. Thomsen, L.L., Lawton, F.G., Knowles, R.G., Beesley, J.F., Riveros-Moreno, V. & Moncada, S. (1994) Nitric oxide synthase activity in human gynaecological cancer. Cancer Res. 54, 1352-1354
22. Thomsen, L.L., Miles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G. & Moncada, S. (1995) Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72, 41-44
23. Cobbs, C.S., Brenman, J.E., Aldape, K.D., Bredt, D.S. & Israel, M.A. (1995) Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 55, 727-730
24. Rosbe, K.W., Prazma, J., Petrusz, P., Mims, W., Ball, S.S. & Weissler, M.C. (1995) Immunohistochemical characterisation of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngology - Head & Neck Surgery. 113, 541-549
25. Chinje, E.C., Hacker, T., Cole, S., Pocock, D.A., Wood, P.J. & Stratford, I.J. (1996) Oestrgen-mediated changes in nitric oxide synthase expression in human breast MDA231 tumours. Br. J. Cancer 73 (suppl.), 8
26. Hall, E.J. (1994) Radiobiology for the Radiologist, J.B. Lippincott Company, Philadelphia
27. Minchenko, A., Bauer, T., Salceda, S. & Caro, J. (1994) Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab. Invest. 71, 374-379
28. Hampl, V., Cornfield, D.N., Cowan, N.J. & Archer, S.L. (1995) Hypoxia potentiates nitric oxide synthesis and transiently increases cytosolic calcium levels in pulmonary artery endothelial cells. Eur. Respir. J. 8, 515-522
29. Melillo, G., Musso, T., Sica, A., Taylor, L.S., Cox, G.W. & Varesio, L. (1995) A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182, 1683-1693
30. 121. Cancer Res. 55, 5296-5301
31. Shweiki, D., Itrin, A., Soffer, D. & Keshet, E. (1994) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (London) 359, 843-845
32. Shweiki, D., Itrin, A., Neufeld, G., Gitay-Goren, H. & Keshet, E. (1993) Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. Clin. Invest. 91, 2235-2243
33. Miles, D.W., Happerfield, L.C., Naylor, M.S., Bobrow, L.G., Rubens, R.D. & Balkwill, F.R. (1994) Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue. Int. J. Cancer 56, 777-782
34. Weiner, C.P., Lizasoain, I., Baylis, S.A., Knowles, R.G., Charles, I.G. & Moncada, S. (1994) Induction of calcium-dependent nitric oxide by sex hormones. Proc. Natl. Acad. Sci. U.S.A. 91, 5212-5216
35. Friedl, A. & Jordan, V.C. (1994) Oestradiol stimulates growth of oestrogen receptor-negative MDA-MB-231 breast cancer cells in immunodeficient mice by reducing cell loss. Eur. J. Cancer 30A, 1559-1564
36. Folkman, J. (1974) Tumor angiogenesis. Adv. Cancer Res. 19, 331-358
37. Gimbrone, M.A., Leapman, S.B., Cotran, R.S. & Folkman, J. (1972) Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 136, 261-276
38. Meyer, R.E., Shan, S., DeAngelo, J., et al. (1995) Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. Br. J. Cancer 71, 1169-1174
39. Wood, P.J., Sansom, J., Stratford, I.J., et al. (1994) Modification of energy metabolism in transplantable and spontaneous tumors by the nitric oxide synthase inhibitor nitro-L-arginine. Int. J. Radiat. Oncol. Biol. Phys. 29, 443-447
40. Stratford, I.J., Adams, G.E., Godden, J. & Howells, N. (1989) Induction of tumour hypoxia post-irradiation: a method of increasing the sensitizing efficiency of misonidazole and RSU1069 in vivo. Int. J. Radiat. Biol. 55, 411-422
41. G-nitro-L-arginine. Cancer Res. 54, 6458-6463
42. Ulhaq, S., Naylor, M.A., Chinje, E.C., Threadgill, M.D. & Stratford, I.J. (1997) S-2-Amino-5-(2-nitroimidazol-1-yl) pentanoic acid: a model for potential bioreductively activated prodrugs for inhibitors of nitric oxide synthase (NOS) activity. Anti-Cancer Drug Design 12, 61-65